GENE ONLINE|News &
Opinion
Blog

2021-09-22| PartnerTechnology

Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing

by Tyler Chen
Share To

Wound dressing can provide more than protection in chronic wound care. With the right material and antimicrobial properties, a dressing can bolster wound recovery and effectively supplement the treatment, especially for diabetes.

Challenges of Diabetes Wounds

 

Studies have shown patients with diabetes have a 10% rate of developing diabetic foot ulcers, and 25% of diabetic patients are admitted to hospital due to foot illnesses. Those patients have high blood sugar, which causes bad blood circulation, weakens white blood cells and increases the number of bacteria. Therefore, they have slow recovery rates and cannot generate enough immunity to combat infection. It’s also hard for treatments to get into the wound.

To accelerate the healing, Taiwan’s Anti-Microbial Savior BioteQ Co., Ltd. (AMS BioteQ) has developed a new antimicrobial dressing for chronic wounds. This dressing is called MEDIACE®. It utilizes the antimicrobial property AirAce extracted from medicinal fungi using the proprietary technology ExtrO. The use of AirAce separates itself from other wound dressings on the market, which implement silver ions for the antimicrobial effect.

Comparison in different brands
Comparison in different brands

No Side Effects So Far in Animal Models

 

Dressings with silver ions take up most of the market, but trials have shown that these dressings can cause redness and allergy when applied to certain types of wounds. Meanwhile, MEDIACE® has demonstrated a positive response in animal models with diabetes and has no side effects so far, paving a way to enter human trials on patients with diabetic foot ulcers.

Furthermore, AMS BioteQ’s dressing exhibits anti-inflammatory and antimicrobial effects on wounds. With a profile of high hydrophilicity and anti-adhesion, the dressing is fitted to use on wounds with all types of wound fluid.

Compared to using polyurethane or lyophilic colloids as the material, the dressing integrates gelatin which contains amino acids, which accelerates wound healing. 

Capturing the Boom in Pet Economy

 

As the pet economy grows with an exponential speed, dressings for animals become a lucrative battlefield. Currently, MEDIACE® has entered animal studies. It has been examined on animal models with Chlamydia, Aeromonas, Enterococcus faecalis, Pseudomonas, and E. coli. The result showed the dressing has an antimicrobial effect on those bacteria.

Now, the dressing is aimed at the human market, targeting decubitus ulcers, foot ulcers, infectious wounds, or hard-to-heal wounds caused by cancer.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
AMS BioteQ Touts Antimicrobial Dressings for Chronic Wound Infections
2022-04-13
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
M&A
Eli Lilly Infuses $1 Billion into Protomer Acquisition to Procure “Next-Gen” Insulin Products
2021-07-15
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top